With the approval of many PD-1 checkpoint inhibitors and the success of lots of clinical trials on cancer immunotherapy, people become more confident with overwhelming the incurable disease. However, there still remain unsolved problems in tumor microenvironment & tumor immunity.
- Tumor Microenvironment and Drug Resistance
- Tumor Microenvironment and Immune Escape
- Regulation of Immunity and Inflammation in Tumor Microenvironment
- Distant Metastasis of Cancer Cells Through Non-Lymphatic Pathways
- Hypoxia, Tumor Microenvironment and Metabolic Reprogramming
- Tumor Microenvironment Targeted and Regulated by Nanotechnology
- Effects of Microenvironment on Immunotherapy
- Treg Cell Heterogeneity and Immunotherapy
- Exosomes and Cancer Immune Tolerance
- Neoantigen-Based Novel Cancer Immunotherapy
- Novel Immune Checkpoints
- Roles of Macrophages in Cancer Immunotherapy
-
-
- Individualized Cancer Vaccines
- New Generation Oncolytic Virus Therapy
- CAR- and TCR-T Cell Therapies
- Bispecific Antibodies
- Clinical Cases and Strategies of Combination of Cancer Immunotherapies and other Therapies
- TMB and Immunotherapy Efficacy Evaluation
-
-
Researchers from Universities and Institutes
Clinicians from Tumor Department and Other Departments
Personnels from the Personnels from the Firms Providing the Biological Therapy
Dear Mr./Ms.
You have registered successfully, the registration information and attention has been sent to the contact and the participants of the mailbox, please note that check. If not received, please contact the general meeting
